Tata India Pharma & Healthcare Fund Direct Growth
About the Fund
Tata India Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 December, 2015. The fund is managed by Meeta Shetty. The fund could potentially beat inflation in the long-run.
Key Parameters
- Tata India Pharma & Healthcare Fund Direct Growth has ₹949 Cr worth of assets under management (AUM) as on Jun 2024 and is less than category average.
- The fund has an expense ratio 0.8.
Returns
Tata India Pharma & Healthcare Fund Direct Growth has given a CAGR return of 14.47% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 47.99%, 17.71% and 27.94% respectively.
Holdings
Tata India Pharma & Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Aurobindo Pharma Ltd, Lupin Ltd, Dr Reddy's Laboratories Ltd, Cipla Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
Investment objective of Tata India Pharma & Healthcare Fund Direct Growth
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. Tata India Pharma & Healthcare Fund Direct Growth has no lock in period.
INDmoney Rank
Fund Overview
| Expense ratio | 0.79% |
Benchmark | S&P BSE Healthcare PR |
| AUM | ₹949 Cr |
| Inception Date | 28 December, 2015 |
| Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 0.25% |
| Lock In | No Lock-in |
TurnOver | 23.3% |
| Risk |   Very High Risk |
Fund Distributionas on (30-Jun-24)
as on (30-Jun-24)
Returns for the month of Jun
Top Growth Drivers | 1M Return |
|---|---|
 Dr Reddys Laboratories Ltd | 13.4% |
 Sun Pharmaceuticals Industries Ltd | 7.2% |
Mutual Fund Insights
Tata India Pharma & Healthcare Fund Direct Growth Highlights
Very High Risk
About the fund
Fund Allocations
AUM size ₹949 Cr
Expense Ratio 0.79%
Frequently Asked Questions
Tata India Pharma & Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 6.68% | 6.68% |
6 Month Returns | 18.04% | 18.04% |
1 Year Returns | 47.99% | 47.99% |
3 Years Returns | 63.1% | 17.71% |
5 Years Returns | 242.77% | 27.94% |
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Tata India Pharma & Healthcare Fund Direct Growth | 2.88 | 4.69 | 8.08 |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Tata India Pharma & Healthcare Fund Direct Growth | 0.93 | 0.9 | 0.77 |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Tata India Pharma & Healthcare Fund Direct Growth | 2.18 | 0.78 | 1.2 |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Tata India Pharma & Healthcare Fund Direct Growth | 14.76 | 14.3 | 16.83 |